Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock (Q36928868)

17 August 2017

1 reference

title

Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock (English)

1 reference

17 August 2017

0 references

1 reference

Billiau A

1 reference

17 August 2017

Vandekerckhove F

series ordinal

1 reference

17 August 2017

publication date

1 December 1991

1 reference

European Journal of Clinical Investigation

17 August 2017

published in

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

559-573

1 reference

The cardiovascular pathophysiology of sepsis

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Endotoxins and haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Viral receptors of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

T-cell responses to Mls and to bacterial proteins that mimic its behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Identification and distribution of two forms of the interleukin 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Cytokines as communication signals between leukocytes and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Self-regulation of procoagulant events on the endothelial cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Identification of an inducible endothelial-leukocyte adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

A human inhibitor of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon-gamma: producer cells, activation stimuli, and molecular genetic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon-gamma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon-gamma: mechanism of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon gamma: a master key in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon messenger RNA is produced constitutively in the organs of normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon gamma and lipopolysaccharide promote macrophage adherence to basement membrane glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interleukin-6: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1991.TB01410.X

10.1111/J.1365-2362.1991.TB01410.X

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kg5eb6t7mjb77eerkywnm2nfuu

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_kg5eb6t7mjb77eerkywnm2nfuu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kg5eb6t7mjb77eerkywnm2nfuu

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/kg5eb6t7mjb77eerkywnm2nfuu

1 reference